A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

While the drug industry was spared that day, he clearly stated that it was next in line. “The pharmaceutical companies are ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

A report from industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), conducted by Ernst & Young, ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.